REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/02/2025
Back to search
Official data from USPTO
EDIGO BIOINFORMATICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EDIGO BIOINFORMATICS
ST13
US500000088137290Class
42
Filing
88137290
Registration
6070251
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
06/03/2025
Trademark type
Word
Nice classes
42
Filing date
09/29/2018
Registration date
06/02/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/02/2020
Last transaction
06/03/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/07/2018
First use in commerce
08/08/2018
Drawing code
4
Owner type
03
Owner location
BEIJING, CN
Examiner
WEIGLE, KATHERINE
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
EDIGENE INC
Representatives
Nihat Deniz Bayramoglu BAYRAMOGLU LAW OFFICES LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific research in the field of genome editinggene editinggenome engineeringgene modulationtranscriptional regulationtranscriptional modulationgenetic diseasesgene therapy and cell therapy; Medical and scientific research information in the field of genome editinggene editinggenome engineeringgene modulationtranscriptional regulationtranscriptional modulationgenetic diseasesgene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/02/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/25/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/24/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/22/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/22/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/17/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/21/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/21/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/21/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/21/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/21/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/21/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/17/2019
GNRT
NON-FINAL ACTION E-MAILED
10/17/2019
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/17/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/03/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/03/2019
IUAF
USE AMENDMENT FILED
09/11/2019
EISU
TEAS STATEMENT OF USE RECEIVED
09/11/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/02/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/05/2019
PUBO
PUBLISHED FOR OPPOSITION
02/05/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/16/2019
ALIE
ASSIGNED TO LIE
12/28/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/07/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
12/06/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/06/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
12/06/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/06/2018
DOCK
ASSIGNED TO EXAMINER
12/04/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/07/2018
NWAP
NEW APPLICATION ENTERED
10/03/2018
Continuous trademark protection
Get notified about every new filing that threatens EDIGO BIOINFORMATICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.